Evaluation of the Abbott ARCHITECT Toxo IgM assay

被引：9

作者：

Sickinger, Eva ^{[2
]}

Braun, Hans-Bertram ^{[2
]}

Praast, Gerald ^{[2
]}

Stieler, Myriam ^{[2
]}

Gundlach, Cordelia ^{[2
]}

Birkenbach, Claudia ^{[2
]}

Prostko, John ^{[1
]}

Palafox, Mary Ann ^{[1
]}

Frias, Edwin ^{[1
]}

Hsu, Stephen ^{[1
]}

Matias, Matthew ^{[1
]}

Pucci, Dominick ^{[1
]}

Hausmann, Michael ^{[2
]}

Sagel, Ulrich ^{[3
]}

Smith, Darwin ^{[1
]}

机构：

[1] Abbott Diagnost, Abbott Pk, IL 60064 USA

[2] Abbott GmbH & Co KG, D-65205 Wiesbaden, Germany

[3] Austrian Agcy Hlth & Food Safety AGES, Inst Med Microbiol & Hyg, A-1096 Vienna, Austria

来源：

DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE | 2009年 / 64卷 / 03期

关键词：

Toxoplasmosis; Toxo IgM; Acute infection; TOXOPLASMA-GONDII INFECTION; IMMUNOGLOBULIN-M ANTIBODIES; AGGLUTINATION-TEST; PREGNANT-WOMEN; RISK-FACTORS; AVIDITY; DIAGNOSIS; SYSTEM;

D O I：

10.1016/j.diagmicrobio.2009.03.016

中图分类号：

R51 [传染病];

学科分类号：

100401 ;

摘要：

Development of the ARCHITECT Toxo IgM assay has been done to assist the clinician in acute Toxoplasma gondii infection detection, especially in pregnant women. Its use, in conjunction with ARCHITECT Toxo IgG and Toxo Avidity assays, will provide an array of assays particularly useful in the monitoring of pregnant females to determine the risk of maternal transmission of the parasite. Specificity results from 2 testing sites, using populations of pregnant females, hospital patients, and blood donors, demonstrated that the assay has an overall resolved relative specificity of 99.89% (confidence interval, 99.68-99.98%). Relative specificity for pregnant female specimens was 99.95% (n = 2031). Excellent seroconversion sensitivity was observed for the ARCHITECT Toxo IgM assay, which was similar to the Abbott AxSYM Toxo IgM assay (Abbott Laboratories, Abbott Park, IL). In more than 90% of the panels tested, the 1st bleed detected in the serial bleeds was the same for both assays. (C) 2009 Elsevier Inc. All rights reserved.

引用

页码：275 / 282

页数：8

共 50 条

[21] Analytical multi-site evaluation of the abbott ARCHITECT® tacrolimus assay
Maine, G. T.
Wallemacq, P.
Goffinet, J.
O'Morchoe, S.
Dickson, D.
Schmidt, E.
Labalette, M.
CLINICAL BIOCHEMISTRY, 2008, 41 (03) : 184 - 184
[22] Analytical multi-site evaluation of the Abbott ARCHITECT® tacrolimus assay
Wallemacq, P.
Goffinet, J.
O'Morchoe, S.
Rosiere, T.
Dickson, D.
Schmidt, E.
Labalette, M.
CLINICAL CHEMISTRY, 2007, 53 (06) : A91 - A91
[23] Phenobarbital assay evaluation on the Abbott Architect: Something old, something new
Beriault, Daniel
Martens, Paul
Yip, Paul
CLINICAL BIOCHEMISTRY, 2015, 48 (15) : 1025 - 1025
[24] Analytical multi-site evaluation of the Abbott ARCHITECT Cyclosporine assay
Maine, G. T.
Wallemacq, P.
Ait-Youcef, H.
Berg, K.
Schmidt, E.
Young, J.
Schmid, R.
Aimo, G.
Marquet, P.
Wonigeit, K.
CLINICAL CHEMISTRY, 2008, 54 (06) : A13 - A13
[25] Analytical multi-site evaluation of the Abbott ARCHITECT Tacrolimus assay
Kahn, S. E.
Vazquez, D.
Meyer, P.
Dickson, D.
Schmidt, E.
Castellani, W.
Pederson, E.
Edwards, M.
Haverstick, D.
Yabut, O.
CLINICAL CHEMISTRY, 2008, 54 (06) : A19 - A19
[26] Analytical multi-site evaluation of the Abbott architect® sirolimus assay
Schmid, R. W.
Lotz, J.
Schweigert, R.
Kergueris, M. F.
Aimo, G.
Friese, J.
Rosiere, T.
Maine, G.
Dickson, D.
Kenney, D.
Lacklier, K.
THERAPEUTIC DRUG MONITORING, 2007, 29 (04) : 507 - 507
[27] Analytical multi-site evaluation of the Abbott ARCHITECT® sirolimus assay
Schmid, R.
Lotz, J.
Schweigert, R.
Friese, J.
Rosiere, T.
Dickson, D.
Kenney, D.
Lackner, K.
CLINICAL CHEMISTRY, 2007, 53 (06) : A93 - A93
[28] Multi-site Analytical Evaluation of the Abbott ARCHITECT Tacrolimus Assay
Wallemacq, Pierre
Goffinet, Jean-Sebastien
O'Morchoe, Susan
Rosiere, Thomas
Maine, Gregory T.
Labalette, Myriam
Aimo, Giuseppe
Dickson, Diana
Schmidt, Ed
Schwinzer, Reinhard
Schmid, Rainer W.
THERAPEUTIC DRUG MONITORING, 2009, 31 (02) : 198 - 204
[29] A comparative evaluation between the Abbott Panbio™ COVID-19 IgG/IgM rapid test device and Abbott Architect™ SARS CoV-2 IgG assay
Batra, Rahul
Olivieri, Luis Gonzalez
Rubin, Delfin
Vallari, Ana
Pearce, Sandra
Olivo, Ana
Prostko, John
Nebbia, Gaia
Douthwaite, Sam
Rodgers, Mary
Cloherty, Gavin
JOURNAL OF CLINICAL VIROLOGY, 2020, 132
[30] Analytical evaluation of the Abbott ARCHITECT cyclosporine assay in comparison to LC/MS/MS and Abbott TDX/FLX
Maine, G. T.
Edwards, M.
Haverstick, D. M.
Sluss, P.
Young, J.
Schmidt, E.
Kettlety, T.
CLINICAL BIOCHEMISTRY, 2008, 41 (14-15) : 1274 - 1274

← 1 2 3 4 5 →